Canada markets closed

Veritas Pharma Inc. (VRT.CN)

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Add to watchlist
0.1800+0.0350 (+24.14%)
At close: 3:59PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-04-30
2018-04-30
2017-04-30
Total Revenue
0
0
0
-
Operating Expenses
Research Development
69.648
148.946
96.361
44.994
Selling General and Administrative
1,823
3,080
12,979
3,303
Total Operating Expenses
1,884
3,239
13,094
3,350
Operating Income or Loss
-1,884
-3,239
-13,094
-3,350
Interest Expense
-
-
0
33.546
Total Other Income/Expenses Net
-7,572
-8,660
-907.666
434.696
Income Before Tax
-9,457
-11,899
-14,002
-2,949
Income from Continuing Operations
-9,457
-11,899
-14,002
-2,949
Net Income
-9,457
-11,899
-13,863
-2,931
Net Income available to common shareholders
-9,457
-11,899
-13,863
-2,931
Basic EPS
-
-1.32
-2.90
-1.00
Diluted EPS
-
-1.32
-2.90
-1.00
Basic Average Shares
-
9,021
4,690
2,841
Diluted Average Shares
-
9,021
4,690
2,841
EBITDA
-
-3,229
-13,983
-2,914